Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Experimental and clinical data have suggested that abnormalities in the serotonergic neurotransmissions in frontal-subcortical circuits are involved in Tourette's syndrome. To test the hypothesis that the brain's 5-HT2A receptor binding is increased in patients with Tourette's syndrome, PET imaging was performed. Twenty adults with Tourette's syndrome and 20 healthy control subjects were investigated with PET-[18F]altanserin using a bolus-infusion protocol. Regions of interest were delineated automatically on co-registered MRI images, and partial volume-corrected binding parameters were extracted from the PET images. Comparison between control subjects and Tourette's syndrome patients showed increased specific [18F]altanserin binding, not only in the a-priori selected brain regions hypothesized to be involved in Tourette's syndrome, but also post-hoc analysis showed a global up-regulation when testing for a overall difference with a randomization test (p<0.03). Increased 5-HT2A receptor binding was found not only in regions closely related to subcortical regions in patients with Tourette's syndrome, but also in most other brain regions. Our data suggest that the serotonergic transmitter system is pathophysiologically involved in Tourette's syndrome and that a clinical trial with 5-HT2A receptor antagonists may be justified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Functional Magnetic Resonance Imaging Study of Tic Suppression in Tourette Syndrome
Peterson, B. S., Skudlarski, P., Anderson, A. W., Zhang, H., Gatenby, J. C., Lacadie, C. M., Leckman, J. F., & Gore, J. C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.326 · Cited by 483
A placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362 · cited 1×
“(Scahill et al., 2003), and ziprasidone and olanzapine, also atypical antipsychotics with high affinity for the 5-HT2A receptor, have in case reports also showed promising treatment effect.”
BackgroundVollenweider, F. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00108-0 · Cited by 305
Higgins, G. A., Enderlin, M., Haman, M., & Fletcher, P. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1549-0 · Cited by 179
Leckman, J. F., Goodman, W. K., Anderson, G. M., Riddle, M. A., Chappell, P. B., McSwiggan-Hardin, M. T., McDougle, C. J., Scahill, L. D., Ort, S. I., Pauls, D. L., et al. (1995) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380241 · Cited by 169
Adams, K. H., Hansen, E. S., Pinborg, L. H., Hasselbalch, S. G., Svarer, C., Holm, S., Bolwig, T. G., & Knudsen, G. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005055 · Cited by 147 · cited 1×
“, 2003) and data from our own laboratory has previously documented that high dose SSRI treatment for more than 3 months does not change 5-HT2A receptor binding (Adams et al., 2005).”
BackgroundSelf-citationStamenkovic, M., Schindler, S. D., Asenbaum, S., Neumeister, A., Willeit, M., Willinger, U., de Zwaan, M., Riederer, F., Aschauer, H. N., & Kasper, S. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00134-6 · Cited by 52
Cited by
Wong, D. F., Brašić, J. R., Singer, H. S., Schretlen, D. J., Kuwabara, H., Zhou, Y., Nandi, A., Maris, M. A., Alexander, M., Ye, W., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301528 · Cited by 253
Neurobiology of Tourette Syndrome: Current Status and Need for Further Investigation: Table 1.
Felling, R. J., & Singer, H. S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0150-11.2011 · Cited by 227
“…combination of diminished levels of the serotonin transporter and elevated serotonin 2A receptor binding (Wong et al., 2008), as well as PET studies identifying abnormalities of tryptophan metabolism in cortical and subcortical regions (Behen et al., 2007; Haugbøl et al., 2007; Wong et al., 2008).”
BackgroundNeuromodulation in Tourette syndrome: dopamine and beyond
Buse, J., Schoenefeld, K., Münchau, A., & Roessner, V. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.004 · Cited by 185
Response Inhibition and Interference Control in Obsessive–Compulsive Spectrum Disorders
van Velzen, L. S., Vriend, C., de Wit, S. J., & van den Heuvel, O. A. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00419 · Cited by 169
Serotonin and molecular neuroimaging in humans using PET
Saulin, A., Savli, M., & Lanzenberger, R. (2012) · Amino Acids · doi:10.1007/s00726-011-1078-9 · Cited by 113
Metadata
- Authors
- Haugbøl, S., Pinborg, L. H., Regeur, L., Hansen, E. S., Bolwig, T. G., Nielsen, F. Å., Svarer, C., Skovgaard, L. T., & Knudsen, G. M.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-02-28
- Volume
- 10
- Issue
- 02
- Pages
- 245
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W1982615078
- Cited by
- 75
- References
- 7
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. https://app.cochat.ai/papers/10.1017/s1461145706006559
- The paper
- Haugbøl, S., Pinborg, L. H., Regeur, L., Hansen, E. S., Bolwig, T. G., Nielsen, F. Å., Svarer, C., Skovgaard, L. T., & Knudsen, G. M. (2007). Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145706006559
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.